Evaxion announces plan to implement ADS ratio change
Portfolio Pulse from
Evaxion Biotech A/S plans to change the ratio of its American Depositary Shares (ADS) from 1 ADS representing 10 ordinary shares to 1 ADS representing 50 ordinary shares, effective around January 13, 2025.
December 30, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evaxion Biotech is changing its ADS ratio from 1:10 to 1:50, which may affect the stock's liquidity and price perception.
The change in ADS ratio from 1:10 to 1:50 means each ADS will represent more ordinary shares, potentially affecting liquidity and investor perception of the stock's value. This type of change can sometimes lead to volatility as investors adjust to the new structure.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100